Evaluating the Impact of Early Versus Delayed 5 Alpha Reductase Inhibitor Treatment on the Risk of Emergent Surgery in Men With Benign Prostatic Hyperplasia

Clinical trial NCT01332487 · COMPLETED

Trial details

NCT number: NCT01332487
Sponsor: GlaxoSmithKline
Status: COMPLETED
Study type: OBSERVATIONAL

Prostatic Hyperplasia

Start date: 2010-08-01
Primary completion: 2010-08-01
Enrollment: 4068

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.